Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Express Scripts

Generated: November 21, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,840,722

« Back to Dashboard

Summary for Patent: 5,840,722

Title: Use of carboxylic acid derivatives as drugs
Abstract:A method of inhibiting endothelin receptors by administering to a patient a compound of the formula I ##STR1##
Inventor(s): Baumann; Ernst (Dudenhofen, DE), Vogelbacher; Uwe Josef (Ludwigshafen, DE), Rheinheimer; Joachim (Ludwigshafen, DE), Klinge; Dagmar (Heidelberg, DE), Riechers; Hartmut (Ludwigshafen, DE), Kroger; Burkhard (Limburgerhof, DE), Bialojan; Siegfried (Oftersheim, DE), Bollschweiler; Claus (Heidelberg, DE), Wernet; Wolfgang (Hassloch, DE), Unger; Liliane (Ludwigshafen, DE), Raschack; Manfred (Weisenheim, DE)
Assignee: BASF Aktiengesellschaft (Ludwigshafen, DE)
Application Number:08/718,377
Patent Claim Types:
see list of patent claims

No matches for this query

Foreign Priority and PCT Information for Patent: 5,840,722

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany44 11 225.4Mar 31, 1994
PCT Information
PCT FiledMarch 23, 1995PCT Application Number:PCT/EP95/01099
PCT Publication Date:October 12, 1995PCT Publication Number: WO95/26716

International Patent Family for Patent: 5,840,722

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China1070701► Subscribe
Czech Republic9602873► Subscribe
Czech Republic290684► Subscribe
Germany4411225► Subscribe
Germany59509537► Subscribe
Denmark0752854► Subscribe
European Patent Office0752854► Subscribe
Spain2162916► Subscribe
Finland963885► Subscribe
Finland118589► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Daiichi Sankyo
Harvard Business School
Cantor Fitzgerald
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus